Difference between revisions of "Team:KAIT JAPAN/contribution"
| Line 15: | Line 15: | ||
<p><a href=http://parts.igem.org/wiki/index.php?title=Part:BBa_K2335003>BBa_K2335003</a></p> | <p><a href=http://parts.igem.org/wiki/index.php?title=Part:BBa_K2335003>BBa_K2335003</a></p> | ||
<p><a href=http://parts.igem.org/wiki/index.php?title=Part:BBa_K2335004>BBa_K2335004</a></p> | <p><a href=http://parts.igem.org/wiki/index.php?title=Part:BBa_K2335004>BBa_K2335004</a></p> | ||
| + | <br> | ||
| + | <br> | ||
| + | <br> | ||
| + | <br> | ||
| + | |||
</main> | </main> | ||
</html> | </html> | ||
{{KAIT_JAPAN_footer}} | {{KAIT_JAPAN_footer}} | ||
Latest revision as of 01:39, 2 November 2017
CONTRIBUTION
- Our team did the following things this year.
- 1. We participated in the interLab study.
- One in five people (more than 20 million people), have hay fever. The number of hay fever patients is expected to increase in the future. So we thought about creating a system to cure hay fever. This system senses IL-10 and produces IL-12.
- 2. To create Cure Allergy Rhinitis, we created and submitted the following five parts.
Contact: kaitjapan@gmail.com Twitter:@KAIT_JAPAN
